Home / Fluoxetine / Austria
AT ATC N06AB03 · updated 2 Nov 2026
Fluoxetine shortage in Austria
Is there a Fluoxetine shortage in Austria?
Yes. As of 2 Nov 2026, 2 Fluoxetine products are reported short in Austria, the first since 1 Jun 2026. The company estimate for the return is 31 Dec 2026. Main reason: active ingredient shortage.
Also short in Canada, France, Italy, Spain, Czechia, Sweden, Australia. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | FluxoMed 20 mg - Kapseln, 14 Stück | S.MED Handels GmbH | 1 Jun 2026 | 31 Dec 2026 | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | FluxoMed 20 mg - Kapseln, 28 Stück | S.MED Handels GmbH | 1 Jun 2026 | 31 Dec 2026 | Active ingredient shortage Verknappung des Wirkstoffes |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).